济南宏方德医药科技有限公司走向世界
业务1: 业务2: 业务3:
当前位置:首页 > 医药行业资讯

最新医药动态

他汀类原料药出口突破500吨 未来竞争更激烈
2013年9月各省新修订药品GMP认证企业进度情况
中药出口遇阻 中成药企业应注意药品安全
上半年中美中药贸易额达2.5亿美元
原料药“服药”:消逝的“黄金时代”
尴尬中西药
关注十八届三中全会对医药行业影响
医药企业转型势在必行
中药注射剂首次问鼎中国知识产权最高奖项
首轮新GMP500多企业未过 药品批文成新目标
新GMP落下第一道帷幕 医药行业格局将改写
药品注册管理工作会议召开 药审改革是核心
全球打响原料药供应链保卫战
生物素:酝酿新一轮市场扩张?
原料药产能过剩市场低迷 出口进入艰难时期
原料药价大涨高景气周期望持续
两部委:重点支持创新药、儿童药、临床急需药物医械研发
18家药企上榜“2017中国企业社会责任500优”
助推医药创新 我国药品审评审批持续提速
国内首个治疗类风湿关节炎的口服JAK抑制剂获批上市
食药监总局通告35批次中药饮片杜仲不合格
埃博拉病毒关键基因合成完成 已交付中国疾控中心
儿童用药有10大误区 正确用药记住3要诀
互联网药品时代来临 医药上市公司“触网”
原料药价格暴涨遭集体“控诉” 最严环保法是最大推手?
68家知名药企业绩大盘点:中药、化药前途晦暗
国内外医药原料药市场现状分析
脑科医药即将迎来大爆炸时代
2014年西药出口同比增长9.28% 原料药仍是出口主力
中国原料药产品出口现状:形势虽转好 障碍仍要清
食药监总局通告5批次药品不合格
Aspirin

发布时间: 2019/12/9 9:59:02   被阅览数: 3310 次     

    TUESDAY, Nov. 19, 2013 (HealthDay News) -- A daily dose of aspirin has become a common treatment for people at high risk for heart attacks or strokes, because it thins the blood and prevents clots from forming.
    But does it matter when during the day you take the drug?
A new Dutch study suggests that people who take aspirin at bedtime might get more protection against heart attacks or strokes.
    The research involved nearly 300 heart attack survivors who were taking aspirin to ward off a second heart attack. During two separate three-month periods, half the patients took 100 milligrams of aspirin after they woke up in the morning while the other half took the same dose at bedtime.
    The researchers wanted to see if taking aspirin at night could better thin a person's blood and potentially lower their heart attack risk, said study author Dr. Tobias Bonten, who serves in the department of clinical epidemiology at Leiden University Medical Center in the Netherlands.
    "Since the 1980s, it's been known that cardiovascular events happen more often in the morning," Bonten said. Morning hours are a peak period of activity for platelets, blood cells that aid in clotting, he said. Doctors suspect that might have a hand in the increased risk of heart attacks and strokes in the morning.
    Aspirin reduces the activity of platelets, and thus reduces the chance that those platelets will clot in the bloodstream and cause a heart attack or stroke, according to the findings. The study is scheduled for presentation Tuesday at the American Heart Association's annual meeting in Dallas.
    Research presented at meetings should be viewed as preliminary until published in a peer-reviewed medical journal.
    The timing of taking aspirin, however, has not drawn much scholarly attention, said Dr. Gregg Fonarow, a spokesman for the American Heart Association.
    "There really have not been studies looking at the timing of aspirin," said Fonarow, a professor of cardiology at the University of California, Los Angeles. "You would imagine that timing of the dose, morning or evening, wouldn't matter very much."
    That's because aspirin has a long-lasting effect on platelets, helping thin the blood for days after it is taken, he said.
    "That's why, prior to surgery, patients are told to hold off on aspirin for five to seven days, and why it continues to thin your blood even when you miss a dose," Fonarow said.
    But the Dutch researchers found that taking aspirin at bedtime reduced platelet activity more than taking it in the morning, apparently because it headed off the body's normal morning surge in platelet activity.
    The team also found that people who took aspirin at bedtime did not suffer any more stomach upset or other side effects than people who took it in the morning, Bonten said.
    The researchers also had hoped that taking aspirin at bedtime would lower a person's blood pressure, something that had been observed in an earlier Spanish study. They found no difference, however, between the blood pressures of waking and bedtime aspirin users.
    You don't necessarily have to start taking your aspirin at night right away, however. Fonarow said the study involved too few people and did not attempt to determine whether taking a bedtime dose will provide better protection against heart attacks or strokes.
    "The key question is whether this is enough of a difference that it would translate to improved clinical outcomes," he said.
    Until larger follow-up studies take place, Fonarow said, people prescribed aspirin for heart problems should continue to take it whenever in the day they like.
    Another study presented at the American Heart Association meeting found that sedentary seniors can use exercise to slow the progression of heart disease.
    Researchers looked at a protein called Troponin T to track the rate of heart injuries in more than 300 people aged 70 and over.
    Doctors found that people who had been assigned to a year of supervised physical activity had three times less increase in their Troponin T levels than people who had not regularly exercised.
    "Our findings suggest biochemical evidence to support the old adage, 'You're never too old to start a physical-activity program to improve cardiac health,'" study author Dr. Christopher DeFilippi, an associate professor of medicine at the University of Maryland School of Medicine, said in a statement.